Literature DB >> 7371135

Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction.

L Hondeghem, B G Katzung.   

Abstract

The effects of quinidine and lidocaine on the maximum upstroke velocity (Vmax) of the ventricular myocardial action potential were compared with the effects predicted by a model over a wide range of driving rates, rhythm disturbances and holding potentials. These rate-, rhythm- and voltage-dependent effects were accurately predicted by the proposed model. The model was also able to predict several previously undocumented properties of the drugs: 1) If lidocaine decreases Vmax of a pulse train, the steady state is reached within a few action potentials. 2) The poststimulation recovery of Vmax in the presence of lidocaine or quinidine can occur in a multiexponential fashion, if the membrane potential is kept at the potential where both the fast (operating mainly at more negative membrane potentials) and the slow (operating at more positive potentials) recovery processes are operative. 3) Hyperpolarization markedly attenuates the rate-dependent drug effects. 4) Combinations of lidocaine and quinidine have a superadditive effect on the Vmax of early extrasystoles.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7371135     DOI: 10.1161/01.cir.61.6.1217

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  28 in total

Review 1.  New concepts affecting the use of antiarrhythmic agents.

Authors:  R L Woosley
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Electrophysiological effects of AFD-21 and AFD-19, new antiarrhythmic compounds on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.

Authors:  I Kodama; K Kamiya; T Kawamura; R Suzuki; J Toyama
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

3.  Rate-dependent activation failure in isolated cardiac cells and tissue due to Na+ channel block.

Authors:  Anthony Varghese; Anthony J Spindler; David Paterson; Denis Noble
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-04       Impact factor: 4.733

4.  Inhibition of the fast sodium inward current in ventricular cardiomyocytes of rats and guinea pigs by a novel potent sodium channel blocking agent.

Authors:  B Koidl; W Schreibmayer; P Wolf; H A Tritthart
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

Review 5.  Mathematical modeling of physiological systems: an essential tool for discovery.

Authors:  Patric Glynn; Sathya D Unudurthi; Thomas J Hund
Journal:  Life Sci       Date:  2014-07-23       Impact factor: 5.037

6.  Modelling frequency- and voltage-dependent effects of a class I antiarrhythmic drug (nicainoprol) on Vmax of the cardiac action potential from guinea-pig papillary muscle.

Authors:  J Weirich; H Antoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

7.  Lidocaine blocks open and inactivated cardiac sodium channels.

Authors:  T Matsubara; C Clarkson; L Hondeghem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

8.  Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscle.

Authors:  E Delpón; C Valenzuela; J Tamargo
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

9.  Electrophysiological effects of OPC-88117, a new antiarrhythmic agent on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.

Authors:  J Toyama; I Kodama; H Honjo; K Kamiya
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

10.  Use-dependent effects of pirmenol on Vmax and conduction in guinea-pig ventricular myocardium.

Authors:  J Hasegawa; S Hirai; N Noguchi; I Hisatome; H Kotake; H Mashiba
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.